03/09/2026 | Press release | Distributed by Public on 03/09/2026 12:40
A hospital CEO recently said to me, "We have more technology than ever. So why does it feel as if we're working harder just to stay in place?"
That question captures the paradox of modern healthcare.
Hospitals today are deeply digitized. Health systems run on electronic health records (EHRs) that document care, enterprise resource planning (ERP) systems that record transactions and analytics platforms that explain performance. Nearly every workflow is captured somewhere in a system.
But digitization alone does not equal performance.
Most digital tools in healthcare operate in isolation, sitting on separate transaction records, data models and reporting environments. When systems don't connect, people become the integrators.
This technology disconnect directly bleeds into operations, where:
The net result is an enterprise that reacts more frequently than it learns.
The problem is not a lack of digitization tools to record what happened. It's a lack of intelligence to guide the strategic decisions that need to happen next.
Overcoming Decision Debt
When margin compression accelerates or shortages spike, healthcare organizations don't fail randomly. They fail along the fault lines of accumulated decision debt.
Decision debt builds when decisions are made with incomplete or siloed information. This forces leaders to revisit the same issues repeatedly, leading to rework, reconciliation and reactive behaviors. Over time, decision debt erodes trust in both the numbers and the system itself.
Artificial intelligence (AI) is often positioned as the cure. But AI layered onto fragmentation does not necessarily create intelligence. On the contrary, it can accelerate chaos - particularly when it is not strategically deployed as part of a platform that solves for that fragmentation.
According to a 2026 surveyof healthcare chief digital and information officers, fewer than half reported measurable returns from their AI investments, citing data and technology fragmentation as primary barriers to success.
The issue is not model sophistication. It is deployment strategy.
Too often, AI enters health systems as a project: Pilot a use case, prove value, report savings and reset the following year.
In that model, learning is episodic, insights remain siloed, and value decays.
On the flip side, an intelligent enterprise does not just analyze discrete project performance. It unlocks value by embedding intelligence into workflows through shared platforms that Sense → Decide → Act → Learn. Guidance is built into execution, enabling continuous decision-making regardless of functional boundaries.
The lesson is simple: platforms learn and compound value because they persist. Projects forget and regress to the mean because they end.
The Supply Chain: Healthcare's Intelligence Test
This AI deployment shift is most urgent in the healthcare supply chain.
If you want to know whether a health system is truly intelligent, look at how it handles drug shortages. More than 250 active drug shortages were reported in 2025, many involving essential generics and sterile injectables. These shortages don't just disrupt operations - they alter clinical pathways, increase safety risks and strain already overextended teams.
A hospital or health system that discovers shortages only after clinicians and patients feel the pain is not managing risk. It is discovering failure in real time.
Yet many systems still manage supply disruption with fragmented procurement platforms, inconsistent inventory visibility and limited predictive insight. The result is predictable: hoarding during perceived scarcity, expensive emergency purchases, manual allocation decisions and contract leakage.
Digitization alone cannot solve this.
What health systems need is embedded intelligence - the ability to detect variation early, automatically recalibrate demand forecasts, align sourcing with clinical priority and continuously learn from utilization patterns.
That is precisely why Premier is making sustained, multi-year investments in AI-enabled supply chain infrastructure. These investments will deliver a unified intelligence layer integrating procurement, pricing, inventory, utilization and contract performance across member systems.
The goal is not another dashboard.
It is durable performance.
When intelligence is embedded in sourcing workflows and shortage-mitigation strategies, decisions no longer reset each budget cycle. Instead, value compounds, variability narrows and scarcity becomes managed rather than chaotic.
Leadership, Not Technology, Determines Value
McKinsey & Company has consistently found that leadership and governance, rather than algorithms, are the primary determinants of AI value realization. Organizations that align domain expertise with AI strategy outperform peers in measurable returns.
This is the hard truth for hospital C-suites: AI strategy is not a technology roadmap. It is a stewardship decision.
Healthcare executives must consider:
Without that discipline, AI becomes noiselayered onto complexity. With it, AI reduces cognitive load, accelerates decision velocity and restores trust in the enterprise's ability to react decisively.
The Strategic Inflection Point
Healthcare is entering an era defined by structural constraints. These include rising demand for care services as the population ages, persistent workforce shortages, escalating supply volatility and increasing regulatory pressure.
There is no operating margin left for fragmentation.
Health systems that continue to pursue episodic pilots will remain trapped in reset cycles that explain performance rather than shape it. On the other hand, those that build enterprise intelligence capabilities, starting with high-leverage domains such as supply chain, will create structural resilience.
Premier's multi-year investments in AI-enabled insights are not about speed for speed's sake. They are designed to ensure learning persists, decisions improve and performance does not unravel when leadership changes or conditions worsen.
Digitization was phase one of healthcare's tech enablement. Intelligence is phase two.
In 2026, healthcare leaders face a binary choice:
One path manages disruption. The other converts disruption into competitive advantage.